Revvity Price to Book Ratio 2010-2025 | RVTY
Historical price to book ratio values for Revvity (RVTY) over the last 10 years. The current price to book ratio for Revvity as of May 22, 2025 is 1.42.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Revvity Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-22 | 90.48 | 1.41 | |
| 2025-03-31 | 105.72 | $63.96 | 1.65 |
| 2024-12-31 | 111.46 | $63.55 | 1.75 |
| 2024-09-30 | 127.51 | $64.88 | 1.97 |
| 2024-06-30 | 104.59 | $63.80 | 1.64 |
| 2024-03-31 | 104.66 | $63.54 | 1.65 |
| 2023-12-31 | 108.88 | $63.79 | 1.71 |
| 2023-09-30 | 110.19 | $62.38 | 1.77 |
| 2023-06-30 | 118.18 | $63.29 | 1.87 |
| 2023-03-31 | 132.51 | $63.77 | 2.08 |
| 2022-12-31 | 139.35 | $58.46 | 2.38 |
| 2022-09-30 | 119.52 | $55.98 | 2.14 |
| 2022-06-30 | 141.19 | $56.78 | 2.49 |
| 2022-03-31 | 173.13 | $56.97 | 3.04 |
| 2021-12-31 | 199.44 | $56.57 | 3.53 |
| 2021-09-30 | 171.83 | $55.14 | 3.12 |
| 2021-06-30 | 153.04 | $37.85 | 4.04 |
| 2021-03-31 | 127.08 | $35.71 | 3.56 |
| 2020-12-31 | 142.08 | $33.33 | 4.26 |
| 2020-09-30 | 124.20 | $28.89 | 4.30 |
| 2020-06-30 | 97.00 | $26.61 | 3.64 |
| 2020-03-31 | 74.38 | $24.79 | 3.00 |
| 2019-12-31 | 95.87 | $25.32 | 3.79 |
| 2019-09-30 | 84.02 | $24.37 | 3.45 |
| 2019-06-30 | 94.97 | $24.37 | 3.90 |
| 2019-03-31 | 94.92 | $23.79 | 3.99 |
| 2018-12-31 | 77.31 | $23.37 | 3.31 |
| 2018-09-30 | 95.66 | $23.16 | 4.13 |
| 2018-06-30 | 71.96 | $22.74 | 3.16 |
| 2018-03-31 | 74.33 | $23.10 | 3.22 |
| 2017-12-31 | 71.72 | $22.68 | 3.16 |
| 2017-09-30 | 67.58 | $23.01 | 2.94 |
| 2017-06-30 | 66.70 | $22.13 | 3.01 |
| 2017-03-31 | 56.76 | $20.11 | 2.82 |
| 2016-12-31 | 50.92 | $19.65 | 2.59 |
| 2016-09-30 | 54.71 | $19.50 | 2.81 |
| 2016-06-30 | 51.05 | $19.09 | 2.67 |
| 2016-03-31 | 48.10 | $18.80 | 2.56 |
| 2015-12-31 | 52.02 | $18.84 | 2.76 |
| 2015-09-30 | 44.57 | $18.36 | 2.43 |
| 2015-06-30 | 50.97 | $18.71 | 2.72 |
| 2015-03-31 | 49.45 | $18.20 | 2.72 |
| 2014-12-31 | 42.22 | $18.16 | 2.33 |
| 2014-09-30 | 42.02 | $18.26 | 2.30 |
| 2014-06-30 | 45.08 | $18.21 | 2.47 |
| 2014-03-31 | 43.30 | $17.94 | 2.41 |
| 2013-12-31 | 39.55 | $17.71 | 2.23 |
| 2013-09-30 | 36.14 | $17.08 | 2.12 |
| 2013-06-30 | 31.05 | $16.61 | 1.87 |
| 2013-03-31 | 32.08 | $16.40 | 1.96 |
| 2012-12-31 | 30.20 | $16.86 | 1.79 |
| 2012-09-30 | 27.98 | $16.95 | 1.65 |
| 2012-06-30 | 24.42 | $16.53 | 1.48 |
| 2012-03-31 | 26.12 | $16.54 | 1.58 |
| 2011-12-31 | 18.83 | $16.28 | 1.16 |
| 2011-09-30 | 18.02 | $17.20 | 1.05 |
| 2011-06-30 | 25.17 | $17.30 | 1.45 |
| 2011-03-31 | 24.51 | $16.93 | 1.45 |
| 2010-12-31 | 24.02 | $16.64 | 1.44 |
| 2010-09-30 | 21.46 | $14.46 | 1.48 |
| 2010-06-30 | 19.10 | $13.94 | 1.37 |
| 2010-03-31 | 22.02 | $13.85 | 1.59 |
| 2009-12-31 | 18.91 | $13.92 | 1.36 |
| 2009-09-30 | 17.61 | $13.72 | 1.28 |
| 2009-06-30 | 15.86 | $13.49 | 1.18 |
| 2009-03-31 | 11.58 | $12.99 | 0.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.665B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.174B | 25.17 |
| Elevance Health (ELV) | United States | $86.874B | 11.21 |
| CVS Health (CVS) | United States | $76.179B | 9.47 |
| Cencora (COR) | United States | $56.230B | 19.56 |
| DiDi Global (DIDIY) | China | $23.297B | 35.36 |
| Natera (NTRA) | United States | $20.821B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.571B | 13.31 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.522B | 0.00 |
| CochLear (CHEOY) | Australia | $11.391B | 0.00 |
| ICON (ICLR) | Ireland | $10.255B | 9.53 |
| Viatris (VTRS) | United States | $9.976B | 3.43 |
| Doximity (DOCS) | United States | $9.570B | 44.57 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.657B | 42.59 |
| Medpace Holdings (MEDP) | United States | $8.422B | 22.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.660B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.994B | 36.97 |
| Bausch + Lomb (BLCO) | Canada | $3.976B | 23.44 |
| Sotera Health (SHC) | United States | $3.480B | 19.77 |
| Surgery Partners (SGRY) | United States | $2.896B | 37.67 |
| Alignment Healthcare (ALHC) | United States | $2.867B | 0.00 |
| Concentras Parent (CON) | United States | $2.744B | 15.86 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.117B | 9.02 |
| GeneDx Holdings (WGS) | United States | $1.921B | 73.99 |
| Premier (PINC) | United States | $1.910B | 14.50 |
| Progyny (PGNY) | United States | $1.791B | 39.42 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.200B | 9.13 |
| Establishment Labs Holdings (ESTA) | $1.066B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.953B | 14.88 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| Nutex Health (NUTX) | United States | $0.901B | 13.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.614B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| LifeMD (LFMD) | United States | $0.523B | 0.00 |
| Enhabit (EHAB) | United States | $0.520B | 42.75 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 11.37 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| SBC Medicals (SBC) | United States | $0.398B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.388B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.214B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.098B | 0.00 |
| So-Young (SY) | China | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.052B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |